Biote Corporation (BTMD) Actualités

Form 8-K - Current report

Biote Schedules First Quarter 2025 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of...

Form EFFECT - Notice of Effectiveness

Form POS AM - Post-Effective amendments for registration statement

Form S-8 - Securities to be offered to employees in employee benefit plans

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Biote Announces Purchase of Shares by Directors and CEO

biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”) a leading solutions provider in preventive health care through the delivery of personalized...

Form 8-K - Current report

Form 8-K - Current report

Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of...